TY - JOUR
T1 - Allelic association and deletions in autosomal recessive proximal spinal muscular atrophy
T2 - Association of marker genotype with disease severity and candidate cDNAs
AU - Wirth, B.
AU - Hahnen, E.
AU - Morgan, K.
AU - Didonato, C. J.
AU - Dadze, A.
AU - Rudnik-schöneborn, S.
AU - Simard, L. R.
AU - Zerres, K.
AU - Burghes, A. H M
N1 - Funding Information:
We are grateful to all SMA families for their kind cooperation and to all clinicians for helping us in providing the blood samples. We thank families of SMA for support given to CJD, Sue Ingraham and Leonard Olien for computer assistance. We thank Drs C.Gilliam and C.Wang for making the primers for the markers Z8 and Z10 available before publication, Dr S-W.Guo for computer programs, and Drs R.Spielman and E.Wijsman for helpful discussions. This research was funded by the Deutsche Forschungsgemein-schaft, Muscular Dystrophy Association (USA), Muscular Dystrophy Association (Canada) and the Canadian Genetic Diseases Network (Federal NCE Program). Furthermore, we thank ENMC for supporting many useful discussions at the meeting of international SMA consortium.
PY - 1995/8
Y1 - 1995/8
N2 - The candidate region for spinal muscular atrophy (SMA) has been defined as a 750 kb interval on 5q13. In this study, we performed allelic association studies in 154 German SMA families with the multicopy markers Ag1-CA (D5S1556); C212 (D5F149S1/S2) and correlated genotype data with deletion of candidate genes. Both multicopy markers recognize 0-3 alleles pro chromosome. Deletions were detected for all copies of the markers Ag1-CA (C272) and C212 in 13 of 88 (15%) type I SMA patients and three of 48 (6%) type II patients. In all informative cases, the deletion was inherited from one parent. In two further cases (one type I and one type III SMA), de novo deletions of only one copy of Ag1-CA and C212 were found. In both cases the patients were homozygously deleted for the survival motor neuron (SMN) gene (exons 7 and 8) but only the type I SMA patient was deleted for the neuronal apoptosis inhibitory protein (NAIP) gene (exons 5 and 6). A third case (type II SMA) showed de novo deletion of SMN, but not of Ag1-CA, C212 and NAIP. Specific alleles of Ag1-CA and C212 showed significant association with SMA, particularly in type I SMA. When the number of marker copies defines genotypes, 1,1 (one allele on each chromosome) is found to be increased in type I SMA (50%) and 1, 2 (one allele on one chromosome and two alleles on the other one) in type II SMA (60%). The 2,2 genotype (two alleles on each chromosome) was found in 4% of type I and II patients. By comparison, pooled normal genotype frequencies were 20, 44 and 36%, respectively. These results suggest a strong correlation between genotype and severity of disease. Based on these data we propose a model which indicates that type I SMA patients are composed of two severe alleles, type II of a mild and a severe, and type III of two mild alleles. Correlation of Ag1-CA genotype with deletion of the XS2G3/NAIP genes indicates that most patients with a deletion have a 1,1 genotype. Owing to the physical proximity of these markers, we propose that a large deletion occurs on type I SMA chromosomes that removes DNA between C212 and XS2G3/NAIP and that type II SMA results from compound heterozygosity for mild (small deletion) and severe mutations.
AB - The candidate region for spinal muscular atrophy (SMA) has been defined as a 750 kb interval on 5q13. In this study, we performed allelic association studies in 154 German SMA families with the multicopy markers Ag1-CA (D5S1556); C212 (D5F149S1/S2) and correlated genotype data with deletion of candidate genes. Both multicopy markers recognize 0-3 alleles pro chromosome. Deletions were detected for all copies of the markers Ag1-CA (C272) and C212 in 13 of 88 (15%) type I SMA patients and three of 48 (6%) type II patients. In all informative cases, the deletion was inherited from one parent. In two further cases (one type I and one type III SMA), de novo deletions of only one copy of Ag1-CA and C212 were found. In both cases the patients were homozygously deleted for the survival motor neuron (SMN) gene (exons 7 and 8) but only the type I SMA patient was deleted for the neuronal apoptosis inhibitory protein (NAIP) gene (exons 5 and 6). A third case (type II SMA) showed de novo deletion of SMN, but not of Ag1-CA, C212 and NAIP. Specific alleles of Ag1-CA and C212 showed significant association with SMA, particularly in type I SMA. When the number of marker copies defines genotypes, 1,1 (one allele on each chromosome) is found to be increased in type I SMA (50%) and 1, 2 (one allele on one chromosome and two alleles on the other one) in type II SMA (60%). The 2,2 genotype (two alleles on each chromosome) was found in 4% of type I and II patients. By comparison, pooled normal genotype frequencies were 20, 44 and 36%, respectively. These results suggest a strong correlation between genotype and severity of disease. Based on these data we propose a model which indicates that type I SMA patients are composed of two severe alleles, type II of a mild and a severe, and type III of two mild alleles. Correlation of Ag1-CA genotype with deletion of the XS2G3/NAIP genes indicates that most patients with a deletion have a 1,1 genotype. Owing to the physical proximity of these markers, we propose that a large deletion occurs on type I SMA chromosomes that removes DNA between C212 and XS2G3/NAIP and that type II SMA results from compound heterozygosity for mild (small deletion) and severe mutations.
UR - http://www.scopus.com/inward/record.url?scp=0029117950&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029117950&partnerID=8YFLogxK
U2 - 10.1093/hmg/4.8.1273
DO - 10.1093/hmg/4.8.1273
M3 - Article
C2 - 7581364
AN - SCOPUS:0029117950
SN - 0964-6906
VL - 4
SP - 1273
EP - 1284
JO - Human molecular genetics
JF - Human molecular genetics
IS - 8
ER -